Morgan Stanley strategist Wilson: Corporate earnings will drive steady gains in US stocks by 2026
Jinse Finance reported that some Wall Street strategists believe strong corporate earnings in 2026 will drive U.S. stocks higher, and the risks surrounding uncertainty over interest rate prospects have proven to be only short-term disruptions. Michael Wilson of Morgan Stanley stated that there are "clear signs" that corporate earnings are recovering, and U.S. companies are enjoying stronger pricing power. Wilson wrote in his report, "Although the Federal Reserve's guidance and government shutdown have put pressure on recent price movements, these are only temporary obstacles. Earnings growth in 2026 will drive strong performance in U.S. stocks."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks
Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.
Crypto prices
More
